Prophylaxis of COVID-19 Disease With Ivermectin in COVID-19 Contact Persons

PREVENT-COVID, PREVENT-COVID, NCT05060666, Jun 2023

4th treatment shown to reduce risk in August 2020, now with p < 0.00000000001 from 106 studies, recognized in 24 countries.

Lower risk for mortality, ventilation, ICU, hospitalization, recovery, cases, and viral clearance.

No treatment is 100% effective. Protocols combine treatments.

6,300+ studies for 210+ treatments. c19early.org

Meta Analysis

Estimated 412 participant ivermectin prophylaxis RCT with results not reported over 3 years after estimated completion.

Results were submitted to the NIH on January 24, 2023 and have not been released over 34 months later.

NIH is normally required to post results on ClinicalTrials.gov within 30 days of submission, regardless of whether the quality control review process is complete1.

3 ivermectin RCTs have results missing long after expected2-4
The trials report an estimated total of 912 patients.

Important missing comments or errors? Let us know.

1. prsinfo.clinicaltrials.gov, prsinfo.clinicaltrials.gov/webinars/Webinar_Posting_Summary_Results_within_30_days.pdf.

2. PREVENT-COVID, Prophylaxis of COVID-19 Disease With Ivermectin in COVID-19 Contact Persons, clinicaltrials.gov/study/NCT05060666clinicaltrials.gov.

3. Moraes et al., Comparative Study of Hydroxychloroquine and Ivermectin in COVID-19 Prophylaxis, NCT04384458, clinicaltrials.gov/study/NCT04384458clinicaltrials.gov.

4. Kamal et al., Ivermectin In Treatment of COVID 19 Patients, NCT04425707, clinicaltrials.gov/study/NCT04425707clinicaltrials.gov.

PREVENT-COVID et al., 24 Jun 2023, Double Blind Randomized Controlled Trial, placebo-controlled, trial NCT05060666 (history) (PREVENT-COVID).